+1-888-308-5802     
News Contact Us

Biotechnology startup Biofourmis raises $35 million in Series B round

Author : Pankaj Singh | Published Date : 2019-05-24 

Biofourmis, a biotechnology startup recently announced that it has collected $35 million in a Series B round led by venture capital company Sequoia Capital India & US-based MassMutual Ventures, along with existing investors like- Openspace Ventures, Aviva Ventures, the corporate venture capital of insurer Aviva & SGInnovate, cites source.

For the record, BiovitalsTM, a digital therapeutic platform of Biofourmis, is based on emerging clinical evidence that combinations of drug and software can improve clinical effectiveness. BiovitalsTM is used with prescription software that employs a wearable biosensor to manage and support patients, diagnosed with heart failure.

Kuldeep Singh Rajput, founder and CEO, Biofourmis, was reportedly quoted saying that the company has made many achievements in the last year, strengthening the company’s regulatory platform with signing of contracts with numerous global pharmaceutical companies. The new funds will allow the company to expand its workforce and commercialization efforts rapidly, while demonstrating the clinical efficiency of digital therapeutics platform with research and development.

For the record, the company develops its treatment algorithms and products by running randomized clinical trials, producing clinical data and demonstrating safety & efficiency.

Earlier in 2017, the startup collected $5 million in a Series A round led by Aviva ventures and NSI Ventures. Biofourmis is expected to utilize funds to expand commercialization efforts in the U.S. and Asia along with increasing its data science, clinical & regulatory and sales & operations focused teams. By the end of 2019, the company aims at growing to more than 100 employees in the U.S. and Singapore.

As per credible sources, the said deal with Biofourmis marks Sequoia India’s 2nd growth stage deal this year, when it has been focusing on early-stage investments from its own funds and early-stage startups in India and South-East Asia, called Surge. Before the current growth deals, Sequoia made a series of growth investment in January, this year, when it led a $25 million investment in Turtlemint, an online insurance platform, as well as a $40 million investment in ed-tech startup, Eruditus.

Source credits: https://www.livemint.com/companies/start-ups/sequoia-leads-35-mn-round-in-biofourmis-1558508398889.html

About Author

Pankaj Singh

Pankaj Singh

Endowed with a post graduate degree in management and finance, Pankaj Singh has been a part of the online content domain for quite a while. Having worked previously as a U.K. insurance underwriter for two years, he now writes articles for fractovia.org and other online portals. He can be contacted at- [email protected] | https://twitter.com/PankajSingh2605

Related News

Cipla launches generic version of Remdesivir at a price of ₹4,000

Published Date: 2020-07-10         Author: Pankaj Singh

Cipla Limited, the multinational pharmaceutical company, has reportedly launched a generic version of the remdesivir drug (Cipremi) at a price of ?4,000 per 100 mg vial, making it among the least priced COVID-19 treatment available across the globe. According to sources familiar with the knowledg... Read More

Revival in UK hotel bookings after COVID-19 downturn, says Premier Inn

Published Date: 2020-07-09         Author: Pankaj Singh

UK has registered a revival in hotel bookings for conventional regional tourist destinations as people have started planning summer trips to the seaside and countryside, stated Premier Inn owner. The Chief Executive of Whitbread, Alison Brittain, has stated that larger cities like London continue... Read More

Fujitsu gravitates toward 'new normal' with new office working style

Published Date: 2020-07-08         Author: Pankaj Singh

Fujitsu Limited, a Japanese multinational IT company headquartered in Tokyo, has reportedly announced that it will boost its shift to becoming a digital transformation organization with an ambitious plan to transform the working style for its employees in Japan in the light of COVID-19 pandemic. ... Read More

© 2020 Fractovia. All Rights Reserved